Browse studies

Find your next paid study

27,293 recruiting studies available now

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose …

Takayasu's ArteritisGiant Cell ArteritisPolyarteritis Nodosa+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NCT02257866

Phase 3

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid …

Symptomatic Venous Thromboembolism (VTE)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT07213778

Phase 2

A Randomized Phase II Trial of Enasidenib-Based Therapies Versus Cedazuridine-Decitabine in Higher-Risk IDH2-Mutated Myelodysplastic Syndrome: A MyeloMATCH Sub-Study

This phase II MyeloMATCH treatment trial compares the usual treatment of cedazuridine-decitabine (ASTX727) to the combination treatment of ASTX727 and enasiden…

Myelodysplastic Syndrome

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06577441

Continuous Wireless Ultrasound to Monitor Fetal Health

This study is a single-center, prospective, and non-randomized feasibility study designed to evaluate the practicality, tolerability, and data quality of short…

Pregnant Woman With Single PregnancyUltrasound Fetal Medicine

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT07676474

TAD1 Risk Assessment for Cardiac Amyloidosis With Evuzamitide (TRACE)

The goal of this study is to learn whether PET-CT imaging using evuzamitide can help diagnose transthyretin cardiac amyloidosis (ATTR-CA) in patients whose sta…

Amyloidogenic Transthyretin (ATTR) AmyloidosisCardiac Amyloidosis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Lorena SaelicesNCT07538518

Real World Asparaginase Therapy Toxicity

This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used i…

Drug Toxicity

Estimated

~$10 – $750

Actual pay is set by the research site.

St. Jude Children's Research HospitalNCT07008027

Phase 1

A Modular Phase I/IIa, Open-label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of AZD0516 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Metastatic Prostate Cancer

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treat…

Metastatic Prostate Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT07181161

Observational

Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles

The purpose of this intervention study is to investigate the effects of daily egg intake on markers of gut health, high-density lipoprotein (HDL), metabolic, a…

Obesity (BMI Equal to or >30)Immune FunctionHDL+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of ConnecticutNCT07844616

Phase 2

A Phase 2 Open-label Study to Evaluate the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least One Treatment (VAY2EXPLORE)

The purpose of this study is to investigate the tolerability of ianalumab (9 mg/kg) with investigator's choice thrombopoietin receptor agonist (IC TPO-RA) in p…

Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07421167

Phase 4

Impact of TRPM8 Agonist on Tear-lipid Thickness

In dry eye (DE), either insufficient aqueous tears are produced or the tears evaporate off the ocular surface too quickly. Meibomian gland dysfunction (MGD) re…

Dry Eye

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of California, BerkeleyNCT07888452

Prospective Study of Symptoms in People With and Without Joint Hypermobility

People with multiple hypermobile joints are diagnosed with Generalized Joint Hypermobility (GJH) when asymptomatic, or Hypermobile Ehlers-Danlos Syndrome (hEDS…

Hypermobile Ehlers-Danlos SyndromePostural Orthostatic Tachycardia Syndrome (POTS)

Estimated

~$10 – $750

Actual pay is set by the research site.

Clarkson UniversityNCT07657507

Phase 3

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult With Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage III…

Advanced Lung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more

Estimated

~$50 – $1,350

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06096844